1 / 18

RESPIRATORY DISTRESS SYNDROME

RESPIRATORY DISTRESS SYNDROME. By Dr. Gacheri Mutua. DEFINITION. Also known as Hyaline Membrane Disease Is a respiratory disorder that affects newborns More common in premature infants especially born 6wks or more before their due date

wardah
Download Presentation

RESPIRATORY DISTRESS SYNDROME

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. RESPIRATORY DISTRESS SYNDROME By Dr. Gacheri Mutua

  2. DEFINITION • Also known as Hyaline Membrane Disease • Is a respiratory disorder that affects newborns • More common in premature infants especially born 6wks or more before their due date • Their lungs have insufficient surfactant, necessary to maintain lung compliance

  3. Disease is exacerbated by: • Cold stress • Hypoxia • Acidosis • Sepsis • Natural history- clinical signs develop within 6hrs of life with progressive worsening over the first 48 to 72hrs of life

  4. Predisposing factors • Prematurity • Male gender and are more likely to die from the disease • Caucasian > black • Caesarean section • Low APGAR score • Maternal diabetes • Congenital hypothyroidisim • Familial predisposition • Twins • Postnatal hypothermia • Maternal malnutrition • Intrauterine growth retardation • Hemolytic disease of the newborn

  5. DIAGNOSIS • Clinical:- • tachypnoea • grunting respirations • intercostals recession, sternal indrawing • nasal flaring • cyanosis • increased oxygen requirements • deranged cardiovascular parameters: HR, BP • Radiological features:- • Air bonchograms with characteristic ground glass appearance • Haematological:- • anaemia • Thrombocytopenia • Blood gas measurements • Mixed metabolic and respiratory acidemia

  6. PREVENTION • Prevent premature delivery • Antenatal steroid therapy • Drugs to mature surfactant synthetic pathways: aminophylline • Prevent asphyxia • Avoid drugs that cause respiratory depression • The course of the disease is altered by exogenous surfactant therapy and assisted ventilation

  7. MANAGEMENT • Non-respiratory • Temperature control • Avoid enteral feeding • IV therapy 5% or 10% dextrose • Closely monitor blood glucose • Antibiotics: penicillin, gentamicin • Assess the baby's circulatory status by monitoring heart rate, peripheral perfusion, and blood pressureAdministerblood or volume expanders, and use appropriate vasopressors to support circulation where necessary.

  8. Respiratory • Airway- place infant in lateral or prone posture rather than supine • Repeated suctioning of pharynx is not required and may cause apnoea and hypoxia

  9. Oxygen • Administer humidified oxygen at flow rates of 6-8l/min • Monitor arterial blood gases, aim to keep pO2 between 50 and 80mmHg • Desired range of monitored pulse oxymeter for infants <34weeks gestation is 88 to 95% but for more mature infants 88 to 100%

  10. INTUBATION AND IPPV • IPPV- Intermittent Positive Pressure Ventilation • Indications: • Cyanosis that persists in spite of maximal oxygen therapy • Severe recurrent apnoea • Respiratory failure (pCO2 >70 and pH <7.2)

  11. CPAP • Continuous Positive Airway Pressure is used to treat preterm infants whose lungs have not yet fully developed such as in RDS or bronchopulmonarydysplasia • It’s functionally similar to PEEP, except that PEEP is an applied pressure against exhalation and CPAP is a pressure applied by a constant flow • CPAP:- • improves survival • decreases the need for steroid treatment for their lungs • decreases the need for IPPV

  12. Surfactant ventilator settings • Ventilator rate 60 breaths per minute • Inspiratory time 0.3sec; expiratory time 0.7sec • PEEP 5cm • Oxygen set to maintain saturations of 88 to 95% • Peak inspiratory pressure (PIP) 20-30cm water

  13. SURFACTANT ADMINISTRATION • Premature neonates with surfactant deficiency and respiratory distress syndrome have an alveolar pool of about 5mg/kg. Full-term animal models have pools of 50-100mg/kg. • Recommended dosages of clinically available surfactant preparations are 50-200mg/kg, approximately the surfactant pool of term newborn lungs

  14. Rapid bolus administration of surfactant after adequate lung recruitment with 3-4cm of positive end-expiratory pressure (PEEP) and adequate positive pressure may improve its homogeneous distribution. • Most neonates require 2 doses; however, as many as 4 doses, given at 6-hour to 12-hour intervals, were used in several clinical trials. • NB: • Dosages could be given as a rapid bolus or intermittent administration. • Prophylactic doses can be given soon after delivery

  15. If the patient rapidly improves after 1 dose, respiratory distress syndrome is unlikely. • Conversely, in infants who have a poor or no response, patent ductus arteriosus (PDA), pneumonia, and complications of ventilation (air leak) should be excluded, especially before subsequent surfactant doses are given.

  16. SUDDEN DETERIORATION • In spontaneously ventilating: • pneumothorax • failure of oxygen supply • increase in severity of the underlying disease • In a ventilated infant: • pneumothorax • endotracheal tube blockage or displacement • mechanical failure with the ventilator • increase in the severity of the underlying lung disease • massive intraventricular haemorrhage • necrotizing enterocolitis, especially if perforation has occurred • patent ductus arteriosus

  17. FAMILY PSYCHOTHERAPY • Staff members (preferably a physician and a nurse) should keep the patient’s parents well informed by frequently talking to them, especially during the acute stage of respiratory distress syndrome

  18. THANK YOU!!

More Related